Recent developments in uterine mesenchymal neoplasms
Authors:
- 13 December 2012
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 62 (1) , 124-137
Abstract
Smooth muscle and endometrial stromal tumours represent the two most common uterine mesenchymal neoplasms that may present diagnostic dilemmas for the practising surgical pathologist. Recent changes in morphological and staging criteria, as well as the discovery of new immunohistochemical markers, have improved the diagnosis and classification of these tumours. We highlight the difficulty in distinguishing tumour cell necrosis from infarct‐type necrosis and the limited utility of p16 immunohistochemical expression in the diagnosis of leiomyosarcoma. We also discuss the controversial use of mitotic activity and necrosis as prognostic factors in endometrial stromal sarcomas. Emerging genetic information has also greatly expanded our understanding of ‘sarcomagenesis’ in both tumour types and may provide insight into potential therapeutic targets for the treatment of leiomyosarcoma and endometrial stromal sarcomas, harboring MED12 (mediator complex subunit 12) mutations and recurrent gene rearrangements, respectively. In this review, we discuss the core updates in the diagnosis and classification of uterine leiomyosarcomas and endometrial stromal sarcomas, highlighting new and important molecular genetic findings that may drive pathogenesis.Keywords
This publication has 143 references indexed in Scilit:
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaProceedings of the National Academy of Sciences, 2012
- Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidneyThe Journal of Pathology, 2012
- Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapyGynecologic Oncology, 2011
- Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosisGynecologic Oncology, 2011
- The human Mediator complex: a versatile, genome-wide regulator of transcriptionTrends in Biochemical Sciences, 2010
- A panel of antibodies to determine site of origin and malignancy in smooth muscle tumorsLaboratory Investigation, 2009
- PDGFR-α as a potential therapeutic target in uterine sarcomasGynecologic Oncology, 2007
- Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcomaCancer, 2004
- Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)Cancer Genetics and Cytogenetics, 2003
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000